Zhou, Q., Yen, A., Rymarczyk, G., Asai, H., Trengrove, C., Aziz, N., . . . Bolotina, V. M. (2016). Impairment of PARK14-dependent Ca(2+) signalling is a novel determinant of Parkinson's disease. Nat Commun.
Stile di citazione ChicagoZhou, Qingde, et al. "Impairment of PARK14-dependent Ca(2+) Signalling Is a Novel Determinant of Parkinson's Disease." Nat Commun 2016.
Citazione MLAZhou, Qingde, et al. "Impairment of PARK14-dependent Ca(2+) Signalling Is a Novel Determinant of Parkinson's Disease." Nat Commun 2016.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.